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Abstract
The limited specificity of nanoparticle (NP) uptake by target cells associated with a disease is one of the principal challenges
of nanomedicine. Using the threshold mechanism of plasmonic nanobubble (PNB) generation and enhanced accumulation
and clustering of gold nanoparticles in target cells, we increased the specificity of PNB generation and detection in target
versus non-target cells by more than one order of magnitude compared to the specificity of NP uptake by the same cells.
This improved cellular specificity of PNBs was demonstrated in six different cell models representing diverse molecular
targets such as epidermal growth factor receptor, CD3 receptor, prostate specific membrane antigen and mucin molecule
MUC1. Thus PNBs may be a universal method and nano-agent that overcome the problem of non-specific uptake of NPs by
non-target cells and improve the specificity of NP-based diagnostics, therapeutics and theranostics at the cell level.
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Introduction
Nanomedicine promises unique abilities to support diagnostic,
therapeutic and theranostic functions at nanoscale, providing
molecule- and cell-level resolution, specificity and selectivity. These
functions are usually mediated through nanoparticles (NPs) that
have to be delivered to specific molecular and cellular targets
associated with a certain pathology or diagnosis. However, this
strategic advantage of nanomedicine is compromised by the
principal limitation in NP targeting. This is that no current method
can deliver NPs only to target cells and molecules because some
amount of NPs always accumulates non-specifically in non-target
cells, thus reducing the specificity and selectivity of nanomedicine.
ThelimitedspecificityofNPtargeting,inturn,requireshigherloads
of NPs in order to achieve the desired diagnostic or therapeutic
effect [1–8]. The high loads of NPs required for therapy delivery
further induces non-specific accumulation and cause toxicity issues
because most NPs are inorganic and of non-biological origin.
Increased NP loads and low targeting specificity result in macro-
rather than nano-resolution for NP medicines. Among NPs, those
based on gold have been exploited most often. Gold NPs have low
toxicity [9,10] and have been used in a relatively wide spectrum of
biomedical applications: optical [6,11–13] and photoacoustic
[14,15] diagnostics, drug delivery [12,16–19], the direct destruction
of target cells through photothermal effects [1–7,20–29], or in
combination with chemotherapy [30]. In addition, gold NPs were
applied in combination with other NPs such as drug carriers and
diagnostic labels [31–37].
The specificity of NP targeting to specific (target) cells was
improved by chemically attaching target-specific vectors to the gold
NPs thus coupling NPs to specific target receptors at cellular
membrane [12,38–47]. This active targeting is more effective
compared to passive targeting with ‘‘bare’’ non-functionalized NPs.
However, many cellular receptors are widely expressed, albeit at very
different levels,on target and non-target cells(bio-heterogeneity). As a
result, a considerable number of actively targeted NPs will still get to
non-target cells through various non-specific mechanisms [1–7].
Therefore, the targeting of NPs to cellsso far cannot provide sufficient
specificity, which slows the translation of nanomedicine to clinic.
The high biomedical specificity of NP-based effects could be
achieved by activating them with a threshold mechanism that would
efficiently discriminate between NPs in target and non-target cells.
These effects are optical scattering, fluorescent and photoacoustic
diagnostics, drug delivery and release, and photothermal therapeu-
tics. Most of the current methods activate these NP effects in cells in
a linear way without a threshold effect and thus such methods often
cannot discriminate between target and non-target cells.
Recently we demonstrated a novel cell-level transient nano-
phenomenon, the plasmonic nanobubble (PNB). This transient
nano-event is triggered by the short pulsed optical heating of gold
NPs and has a threshold of generation that is sensitive to multiple
variables including clustering of NPs [48–51]. A PNB is a vapor
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upon its activation with a short laser pulse whose energy is
converted by the gold NP into heat through the mechanism of
plasmon resonance [3–5,12,13,49,52,53]. PNB generation thresh-
old energy was found to depend upon NP structure, size and
aggregation state and was found to be lowest for NP clusters,
nanostructures with tightly aggregated NPs [48,54,55]. This
unique physical property of PNBs allows their selective generation
under low laser pulse fluence only around large clusters of NPs,
while the same level of laser fluence was below PNB generation
threshold for single NPs or their small clusters. As biomedical
agents, PNBs demonstrated their potential for optical diagnostics
[40,56–58], delivery and on demand release of therapeutic and
genetic cargo [59–62], elimination of target cells [38,49,63,64],
microsurgery [65,66] and theranostics [40,55,63].
We hypothesized that combining the threshold nature of gold
NP-generated PNBs with their biomedical properties could
significantly improve the precision and specificity of gold NP-
based biomedical effects (Figure 1). Despite extensive previous
studies of PNBs and especially of gold NPs in cells, validation of
this hypothesis requires direct comparison of the specificity of NPs
and PNBs in target vs non-target cells, a study that has not
occurred. To validate this hypothesis we compared the abilities of
PNBs and gold NPs to discriminate between target and non-target
cells under identical treatment conditions in six different in vitro
models and molecular targets. We demonstrate an efficient and
universal solution for overcoming the influence of non-specific
accumulation of NPs in non-target cells and to achieve high
cellular specificity of biomedical effects of NPs.
Methods
1. Nanoparticles and their clusters
We have used three different types of gold nanoparticles (NP):
commercially available 60 nm spheres (NSP) and fabricated
50 nm hollow gold nanoshells (NS) and 110 nm gold NS with
silica core inside. Gold NSP were provided and conjugated with
cell-specific antibodies by Bio Assay Work LLC (Ijamsville, MD).
50 nm hollow gold NSs were synthesized by galvanic replacement
of gold on a silver core according to Zasadzinski et. al. [67] The
advantages of this type of NP include low toxicity, reliable
conjugation properties, relatively high photothermal efficiency and
maximal plasmonic nanobubble (PNB) generation efficacy in the
biologically safe near-infrared spectral region with reducing the
PNB generation threshold laser fluence. The 110 nm gold NS with
silica core inside were designed and fabricated as described in
previously [4]. NSs structure and size were verified with TEM
(JEOL 2010, Jeol Ltd., Tokyo, Japan). Optical density spectra of
NPs were obtained in water with a spectrophotometer (the USB
650 Red Tide spectrometer, Ocean Optics, Inc, Dunedin, FL).
For the study of PNB generation around NP clusters in water,
NS clusters were prepared by adding sodium chloride to a
suspension of single NSs. Clusters were re-suspended in water to
provide low surface density that provided exposure of only one NP
cluster by a single laser pulse. Next, we added 5 ml polysterene
microspheres of 7.6 mm diameter (Spherotech Inc., Lake Forest,
IL) were added into 50 ml of the NS clusters suspension. These
microspheres have been used as spacers between the two glasses (a
standard microscope slide and coverslip of 18 mm diameter) to
provide a specific height (7.6 mm) of the sample volume. Clusters
were re-suspended in water so that their low surface density would
exclude the exposure of closely located nanoparticles under laser
irradiation. To minimize the effect of cluster size heterogeneity, we
used only the clusters with close levels of pixel image amplitudes of
their optical scattering images. Each cluster was positioned in the
center of the excitation laser beam and was exposed to a single
laser pulse.
2. Molecular targets and cell models
We studied the six cell models representing four molecular
targets (Table 1). Each pair of cells represented target cells with
high level of expression of specific molecular target and non-target
cells with low level of the expression of such molecular target.
Details on culturing cells and monitoring of the expression level of
molecular targets can be found in Text S1 and Figure S1 and
Figure S2. NP clusters were selectively formed in target cell though
the two-stage mechanism (Figure 1a):
– at the first stage we used target-specific antibodies to provide
higher accumulation of gold NPs at the membranes of target
cells compared to the NP accumulation at membranes of non-
target cells. This stage did not provide desired specificity of the
targeting but at the same time delivered much more NPs to
target cells compared to non-target cells;
– at the second stage we engaged receptor-mediated endocytosis
so that target cells self-assembled the large clusters of gold NPs
in their endosomal systems [38–46].
The targeting parameters such as the concentration of NPs and
the incubation time were optimized to achieve maximal difference
Figure 1. PNBs and NPs in target (left panels) vs non-target (right panels) cells. A: gold NP conjugates are collected at cellular membranes
and are clustered during endocytosis resulting in the largest NP clusters in target cells. B: Excitation laser pulse (green) of low fluence induces PNBs
only around the largest NP clusters (i.e. only in target cells) because the PNB generation threshold fluence for single NPs and small clusters (non-
target cells) is higher than the fluence of the laser pulse. C: Optical scattering of the probe laser radiation (red) by PNBs provides its real-time imaging
and monitoring in the individual cell (ID: image detector, RD: response detector).
doi:10.1371/journal.pone.0034537.g001
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Applied targeting method does not eliminate the non-specific
uptake of NPs, however, it provides the formation of the largest
NP clusters only in target cells for target-specific generation of
PNBs. Table 1 resumes experimental conditions applied for each
molecular target and cell model. Sphere- and shell-type NP
conjugates did not induce any considerable cytotoxicity in either
target or non-target cells within 48–72 h (see Supplementary
Information for details). Both cell cultures were identically treated
with NPs conjugated to target-specific antibodies.
3. Generation of plasmonic nanobubbles
PNBs were generated due to transient heating of gold NPs with
single laser pulses to the temperatures well above the evaporation
threshold for the liquid environment of NPs (Figure 1b). We
employed single short laser pulses of 70 and 400 ps, 532 nm (for
excitation of solid gold spheres) and 787 nm (for excitation of gold
nanoshells) (PL-2250, Ekspla and and STH-01, Standa Ltd,
Vilnius, Lithuania). A short laser pulse maximized the efficacy of
NP heating by preventing three negative processes: thermal losses
through thermal diffusion [68], NP photodamage [69] and
attenuation of incident optical pulse by developing vapor bubble
[70]. Such vapor nanobubble uses thermal energy generated by
gold NPs through the mechanism of plasmon resonance [3–
5,12,13,49,52,53] and this thermal energy (1) determines maximal
diameter and lifetime of PNB and (2) is determined by fluence of
laser pulse [54,55]. Fast adiabatic expansion of the PNB provides
efficient thermal insulation of its environment from the internal
heat [54,71]. The described mechanism also explains the origin of
the term ‘‘plasmonic nanobubbles’’: such vapor bubbles get their
energy through plasmon resonance of gold NPs and act at
nanoscale as mechanical, optical and acoustic nano-agents.
Optical generation and detection of the PNBs was performed
with a photothermal laser microscope that we developed
previously [40,48]. The laser pulse fluence (10–90 mJ/cm
2) was
experimentally determined for each pair of the target and non-
target cells to exceed the PNB generation threshold in target cells
and to be below PNB generation threshold for non-target cells (see
also Text S1 and Figure S3).
4. Optical detection of NPs and PNBs
To image and quantify the uptake of gold NPs by cells we
imaged and measured optical scattering by gold NPs in individual
cells. Amplitude of optical scattering signal correlates to the size of
scattering nanoobject [54,56] even if the latter is below optical
diffraction limit and cannot be seen in a microscope. As a rule we
used laser confocal microscopy (LSM 710, Carl Zeiss Microima-
ging Inc., Germany) to obtain the stack of several images per each
cell (in case of A549 cells the NP scattering was imaged and
quantified with regular inverted microscope). In each population
(sample) 30–50 cells were analyzed and the population-average
image pixel amplitudes were calculated for each cell sample.
Excellent optical scattering properties of a PNB [54] were used for
its imaging in water and cells (Figure 1c) with two probe laser
beams, pulsed probe beam (576 nm, 70 ps, 0.1 mJ/cm
2) and
continuous probe laser (633 nm). This provided two independent
signals and two optical metrics of PNB (Figure S3): optical
scattering time-resolved image pixel amplitude and duration of
optical scattering time response (measured independently and
simultaneously with optical scattering image). First, time-resolved
optical scattering was used for imaging of PNBs and analyzing of
their brightness. The maximum pixel amplitude of PNB was used
as PNB metric (see Text S1 detailed definitions). The second PNB
metric was independently obtained with another, continuous,
probe laser (Figure S3). The PNB-induced scattering of a part of
the probe beam decreased its axial amplitude, resulting in a
Table 1. Cell models and conditions of their treatment with NP and laser pulses.
Incubation conditions
Laser pulse
parameters
Mole-
cular
target NP Vector
Cells:
target/non-target
NP con-
centratio, NP/
ml
Incu-bation
time Dura-tion, ps
Wave-
length,
nm
Fluence, mJ/
cm
2
EGFR 50 nm
NS
Panitu-mumab HN31/NOM9 2.4*10
10 24 h 70 820 30
EGFR 60 nm
NSP
Panitu-mumab HN31/NOM9 2.4*10
10 24 h 70 532 60
EGFR 60 nm
NSP
C225 HN31/NOM9 2.4*10
10 24 h 70 532 60
-6 0 n m
NSP
none HN31/NOM9 2.4*10
10 24 h 70 532 60
EGFR 110 nm
NS
C225 C42B/HS5 1.2*10
11 30 min 500 787 38
MUC1 60 nm
NSP
214D4 HES/HS5 2.4*10
10 1 h 500 532 40
PSMA 60 nm
NSP
Anti-PSMA C42B/HS5 1.2*10
11 30 min 500 532 60
CD3 60 nm
NSP
OKT3 CD3+ T-cells/CD32 BMC 1.2*10
11 30 min 70 532 37
CD3 60 nm
NSP
OKT3 J32/JRT3-T3.5 1.2*10
11 45 min 500 532 63
EGFR 60 nm
NSP
C225 A549/Fibro-blasts 6*10
10 30 min 500 532 30
doi:10.1371/journal.pone.0034537.t001
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probe beam. Thus we registered the time response of the probe
laser radiation to the transient scattering effect of the PNB. This
mode provided the monitoring of PNB growth and collapse, and
delivered the PNB lifetime that characterizes its maximal diameter
[23,24,48,54,55]. All three described above metrics were obtained
for individual cells and were averaged for each population of target
and non-target cells. This provided maximal precision of NP and
PNB analysis.
Results
1. The PNB creates a threshold response to the optical
excitation of gold NPs
The physical mechanism of PNB specificity was studied by
generating and analyzing single PNBs around individual gold NP
clusters of variable size in water. NP clusters were prepared by
aggregating gold NPs (hollow gold 50 nm nanoshells) in a high salt
solution. We used single and clustered gold spheres (60 nm) and
hollow shells (50–60 nm) (see Text S1 for details). Optical
scattering imaging of NP clusters was used to characterize their
size through the scattering image amplitude since optical scattering
brightness correlates to the size of the scattering object [20,72–74].
PNBs were detected around specific individual NP clusters with
two simultaneous techniques, time-resolved optical scattering
images and time response (see Text S1). Three PNB parameters,
these being the probability of PNB generation, scattering image
amplitudes and time response durations, were measured for
individual PNBs as functions of the optical fluence of the excitation
laser pulse and the brightness of the NP cluster. The excitation
fluence that corresponded to the probability of PNB generation of
0.5 was defined as the PNB generation threshold. First we studied
the dependence of the PNB threshold in a single pulse mode upon
NP cluster size, measured through its scattering image amplitude
(Figure 2a). We observed a significant reduction of the threshold
fluence with the NP cluster size. Thus a low fluence was sufficient
to generate PNBs around large NP clusters but was not sufficient
to induce PNBs around single NPs or small NP clusters. This was
demonstrated by exposing multiple NP clusters of various sizes to a
single laser pulse of low fluence. We observed the selective
generation of PNBs only around the largest NP clusters (Figure 2b)
whose threshold was lower than the applied fluence. The PNB
threshold for smaller clusters was above this fluence and, therefore,
such small NP clusters did not return PNBs in response to optical
excitation.
The dependence of the PNB threshold fluence upon cluster size
can be explained through the mechanism of PNB generation
around superheated NPs. Merged thermal fields of several tightly
aggregated NPs form a common thermal field and vapor layer
around the cluster. The initial vapor pressure in such a vapor layer
is determined by the fluence of the laser pulse that is converted
into heat by each NP in a cluster. Next, the external pressure of
surface tension (that needs to be overcome to allow the expansion
of the vapor) is inversely proportional to the radius of the vapor-
liquid boundary [75–77] and, therefore, decreases with cluster
size. We previously analyzed the mechanism of PNB generation
around NP clusters versus single NPs [54]. In addition to the
above thermal and hydrodynamic factors, NP clustering may
enhance their optical absorbance [78,79], thus additionally
increasing the released thermal energy and the initial vapor
pressure. All these factors cause the decrease of the PNB
generation threshold fluence with cluster size. With the fluence
of the excitation pulse below the threshold, the PNB does not
emerge, and, therefore, creates no impact, unlike NPs (Figure 2b).
Contrary to a gradual increase in optical scattering amplitude of
NP clusters with their size, the PNB scattering signals responded to
a threshold NP cluster size (Figure 2b). This resulted in the
selective generation of PNBs only around the largest NP clusters,
while no PNBs emerged around single NPs and small clusters
under identical excitation conditions. This cluster-threshold
mechanism of PNBs created a unique opportunity to improve
the specificity of NP-based effects.
2. Cellular specificity of NPs and PNBs
Since the largest NP clusters can be selectively formed in target
cells through the receptor-medicated endocytosis of NPs [38–46],
we further studied the NP cluster-PNB mechanism in living cells in
order to compare the cellular specificity of NPs and PNBs under
identical conditions of NP targeting and optical excitation. Several
different molecular targets were investigated in vitro in cell systems
that included cells with a high level of molecular target expression
(target cells) and a low level of the expression of the same
molecular target (non-target cells).
We studied cell models representing lung (A549), head and neck
(HN31), prostate (C4-2B), epithelial (HES, a WISH/HeLa
derivative) and blood (Jurkat J32) cancers and also human T-
cells that are used for gene therapies of cancer (see the detailed
description of experimental models in Text S1). Both solid gold
spheres (NSP) and gold nanoshells (NS) were conjugated to target-
specific antibodies (Table 1, see also Text S1) and were
administered under concentrations and incubation times that
were experimentally optimized for each cell model for maximal
uptake of NPs (see Text S1). After removing unbound NPs, the
accumulation of gold NPs in individual cells was imaged and
measured through gold NP-specific optical scattering (Figure 3a).
Similar to previous experiments, we measured cell-averaged levels
of scattering image amplitudes in target and non-target cells
(Figure 4 row a). In all six cases we observed a higher level of NP
signals in target cells, but all non-target cells also showed a
significant level of NP uptake and formation of NP clusters
(Figure 3a, 4a) so that the ratio of the NP signal for target versus
non-target cells was below 10. However, higher pixel image
amplitudes in target cells indicated the formation of the largest NP
clusters in target cells.
Next, target and non-target cells were identically treated with
single laser pulses within the range of pulse fluences for PNB
generation around NP clusters. For each cell model we
experimentally determined the level of excitation pulse fluence
that provided the generation of PNBs mainly in target cells and did
not induce PNBs in non-target cells (Figure 3 b,c,d). The optical
scattering images and time responses of individual cells were
processed to compare the corresponding metrics for NP
accumulation (Figure 4, row a) and PNB generation (Figure 4,
row b,c) in target and non-target cells. Compared to NP signals,
the PNB signals showed a much higher discrimination between
target and non-target cells in all six. Cellular specificity of NPs and
PNB was quantitatively shown through the ratios of the target cell
signals to the corresponding signals in non-target cells (shown as
colored numbers in each frame of Figure 4). Compared to NPs,
the PNBs improved cellular specificity in some models by more
than one order of magnitude. While the non-target cells showed
significant uptake of NPs and even their potential aggregation into
small clusters, no PNBs, or very small ones, were observed in non-
target cells under identical treatment conditions (Figures 3 and 4).
The difference in cellular specificity of NPs and PNBs can be
clearly seen in experiments with a co-culture of target (labeled with
green fluorescent protein for identification) and non-target cells
(Figure 3). At a specific fluence of the excitation laser pulse
Cellular Specificity of Plasmonic Nanobubbles
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2 at 778 nm) only target cells yielded PNBs while even
adjacent non-target cells with gold NPs did not. Such a difference
between NP and PNB signals was observed for all six cell models:
adherent (HN31, HES, A549) and suspension (C4-2B, T-cells,
Jurkat) cells, and for all molecular targets: receptors (EGFR, CD3,
PSMA) and glycoproteins (MUC1). These results indicate the
universal nature of the high cellular specificity of PNBs compared
to that of gold NPs. Therefore, PNB provided better discrimina-
tion between target and non-target cells even when such cells were
heterogeneously mixed.
3. Effects of the NP targeting vectors on the PNBs
The results reported above were obtained by using one type of
antibody that was specific for the target cell in each cell model. In
order to determine the role of the targeting vector in cellular
specificity of PNBs, we completed three additional experiments in
Figure 2. Parameters of PNBs generated around gold NP clusters in water for gold nanoshells. A: PNB generation threshold fluence of
the excitation laser pulse as function of NP cluster size (measured through optical scattering amplitude of NP cluster image for individual clusters); B:
PNB lifetime and scattering brightness as function of the NP cluster size (measured through optical scattering amplitude of NP cluster image) at
specific fluence of the excitation pulse (778 nm, 22 mJ/cm
2).
doi:10.1371/journal.pone.0034537.g002
Figure 3. Images and signals of gold NPs and PNBs in co-culture of target (HN31, labeled with Green Fluorescent Protein for
identification) and non-target (NOM9) cells identically treated with 60 nm gold NSP-C225 conjugates (specific to EGFR that is
overexpressed in target cells). A: overlay of bright field, fluorescent and scattering images shows target cells (green) and gold NPs (red) that can
be found in both types of cells (the arrows show NP clusters in non-target cells); B: time-resolved scattering image of the same field shows PNB
images (bright white spots) only in target cells; C,D: optical scattering time-responses of individual target (C) and non-target (D) cells show the PNB-
specific signal only for target cell and the definition of the PNB lifetime of PNBs; time is measured from the moment of the exposure to the excitation
laser pulse.
doi:10.1371/journal.pone.0034537.g003
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target (HN31) and non-target (cells) as a function of the targeting
vector.
The first experiment compared NP and PNB signals for
identical NPs with and without target-specific antibody (active vs
passive targeting). We incubated cells identically with bare gold
60 nm spheres and with the conjugates of the same spheres to
Panitumumab antibody that is specific against EGFR. The
conditions of NP treatment were identical to those in Figure 4
and the laser treatment (532 nm, single pulse, 60 mJ/cm
2) was
identical for all cells. We observed no PNBs at all in target and
non-target cells treated with ‘‘bare’’ NPs (Figure 5a) despite using
an optical fluence that was above the PNB generation threshold
even for the smallest clusters, but was below the PNB threshold for
single NPs (Figure 2a). NP scattering amplitudes of both types of
cells were comparable to those of the background scattering of
intact cells. At the same time the cells treated with NP-
Panitumumab conjugates (Figure 5a) returned a result similar to
that observed earlier (Figure 4). PNB lifetime demonstrated a
much higher contrast between target and non-target cells
compared to scattering amplitudes measured for NPs. This
experiment demonstrated that the important contribution of the
targeting vector to NP uptake. The use of bare, non-conjugated
NPs under the same targeting conditions (NP concentration and
incubation time) was insufficient for achieving detectable NP
effects.
The second experiment analyzed the effect of two anti-EGFR
antibodies on NP and PNB signals for the same cell model of
target (HN31) cells (Figure 5b). We applied two different
antibodies, C225 and Panitumumab, that were separately
conjugated to identical NPs (60 nm gold spheres). NPs were
targeted in the following combinations that used identical
concentrations of NPs and incubation times (Figure 5b). These
combinations were (1) NP-C225, (2) NP-Panitumumab, (3)
sequential targeting with Panitumumab alone and then with NP-
C225, (4) sequential targeting with C225 alone and then NP-
Panitumumab conjugates and (5) joint targeting of NP-C225 and
NP-Panitumumab conjugates. NPs in cells were measured with
NP-specific optical scattering amplitudes and the PNBs were
characterized in the same cells with their lifetime measured under
identical laser exposure to a single pulse (532 nm, 60 mJ/cm
2)
(Figure 5b). As can be seen from the data in Figure 5b, the PNB
response to the variation of targeting conditions is more sensitive
than that of NPs, whose uptake did not vary significantly. In
particular, NSP-Panitumumab conjugate alone provided maximal
PNB generation efficacy compared to all other combinations. Pre-
treatment of the cells with free antibodies reduced the efficacy of
PNB generation (lower lifetime) to possible blocking of EGFR with
the administered free antibody during pre-treatment and, as a
result, reduced uptake of NPs. It is interesting to note that the joint
targeting of both NP conjugates also reduced the efficacy of PNB
generation compared to Panitumumab alone (Figure 5b). This
experiment demonstrated the superior sensitivity of PNBs
compared to NPs to the targeting vector.
Finally, we compared the PNBs and NPs under the simulta-
neous combinatorial action of the two antibodies, each conjugated
to a different NP type. This experiment employed the ‘‘rainbow’’
method of PNB generation which we recently developed [63,80].
Figure 4. Cell population-averaged levels of optical scattering signals obtained for individual target (solid bar) and non-target
(hollow bar) cells in six cell models represented by target/non-target cells/molecular targets: Squamous cell carcinoma, HN31/NOM9/
EGFR (treated with 50 nm NS-Panitumumab conjugates); Lung cancer, A549/Fibroblast/EGFR (treated with 60 nm NSP-C225 conjugates); Epithelial
cancer, HES/HS5/MUC1 (treated with 60 nm NSP-214D4 conjugates); Prostate cancer, C2-4B/HS5/PSMA (treated with 60 nm NSP-anti-PSMA
conjugates); Leukemia, J32/JRT3-T3.5/CD3 and human T-cells, T-cell/BM/CD3 (treated with 60 nm NSP-OKT3 conjugates) for: Row A (red): gold NP
amplitude of scattering image of gold NPs (a metric for the uptake of NPs by cells; Row B (purple): time-resolved scattering image amplitudes of
PNBs; Row C (blue): PNB lifetimes. The ratio of the signals for target/non-target cell is shown for each parameter and cell model and indicates the
cellular specificity of NPs (row A) and PNBs (rows B,C).
doi:10.1371/journal.pone.0034537.g004
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cluster and simultaneously excited with two different laser pulses.
We used the cell model of C4-2B cells described above. Gold
nanospheres (NSP) of 60 nm, PNB excitation peak at 532 nm, and
silica-gold nanoshells (NS) of 110 nm, PNB excitation peak at
787 nm, were conjugated to target-specific antibodies against
PSMA [81] and non-specific antibody against EGFR (C225) as
NSP-PSMA (spheres) and NS-C225 (shells), respectively. The target
cells were incubated in three different combinations using identical
nanoparticle concentration and incubation time. These combina-
tions were (1) NSP-PSMA, (2) NS-C225 and (3) simultaneously with
both conjugates. The uptake of all NPs was measured in individual
cellsthroughopticalscatteringforthethreecasesanddidnotshowa
significant difference (Figure 5c). PNBs were generated with two
different simultaneous laser pulses of the same fluence of 38 mJ/
cm
2, each pulse wavelength matching the peak wavelengths of NSP
and NS, respectively. In case 1, a single pulse was applied at
532 nm,incase 2 a single pulse wasapplied at 787 nmand incase 3
the two pulses, 532 nm and 787 nm, were simultaneously applied
(Figure 5c). The laser fluence levels were adjusted to detect small
PNBs in any of the three cases. Under such settings we detected
similar small PNBs for cases 1 and 2 that employed one type of NP
and one wavelength for optical excitation. However, in case 3, the
PNB generated with the rainbow method showed a significant
(about10-fold) increaseinthe PNB lifetimecompared tocases1 and
2, which was much higher than the corresponding difference in NP
scattering. The latter did not differ much for all three cases
(Figure 5c). The PNB signal in case 3 apparently showed a
synergistic enhancementofthePNBcompared tocases1 and2,and
even compared to the results presented above (Figure 4). Compared
to Figure 4 (C4-2B cell, PNBlifetime) we increased the PNB lifetime
with the rainbow mechanism by almost one order of magnitude,
while at the same time reducing the laser fluence from 60 mJ/cm
2
(Figure 4 for PSMA target) to 38 mJ/cm
2. This was achieved
through the simultaneous excitation of the two different plasmon
resonances in co-localized NPs of two different types, NSP and NS.
These were mixed in one cluster and simultaneously received two
laser excitation pulses in the rainbow mode of PNB generation
(details of the rainbow PNB method can be found in [63,80]).
The three experiments described above demonstrate the role of NP
targeting vectors in PNB generation. Depending on the vector
employed, the PNBs varied from zero (for non-specific uptake of bare
NPs) to the synergistic enhancement of the PNB in the rainbow mode.
Discussion
1. Mechanism of cellular specificity of PNBs
As can be seen from Figure 4, the PNB method can better
discriminate between target and non-target cells compared to NPs.
Cellular specificity of PNBs was more than one order of magnitude
higher than that of NPs (this can be clearly seen by comparing the
ratios of the corresponding signals for target and non-target cells).
Such an effect was achieved through the cluster-threshold
mechanism of PNBs that prevents the generation of PNBs around
non-specifically targeted single NPs (and their small clusters). This
is due to the dependence of the PNB threshold upon cluster size
and the low optical fluence applied. Since a similar effect of PNB
specificity was observed in the 6 different cell models and for the
different molecular targets we conclude that the mechanism of
such high specificity should be universal and can be applied to
many other cell targets that express specific molecules. The
universal nature of PNB specificity can be explained by (1) the
threshold mechanism of PNB generation, (2) the dependence of
the PNB generation threshold fluence upon the size of the NP
cluster (Figure 2) and (3) the universal mechanism of NP clustering
through receptor-mediated endocytosis [38,39,49]. The latter is
responsible for the maximal size of the cluster that determines the
minimal PNB threshold fluence (Figure 2a) and other parameters
(Figure 2b) of a PNB generated in a cell targeted with NPs. Since
NP clustering is a result of endocytotic internalization and
concentrating of NPs into a cluster, this is a universal mechanism
for any living cell. The size of NP cluster in a cell and its ability to
generate the PNB depends upon several factors:
Figure 5. Influence of targeting vectors on NP scattering
amplitude (red) and PNB lifetime (blue) in individual target
(solid bars) and non-target (hollow bars) cells. A: Target (HN31)
and non-target (NOM9) cells identically treated with bare 60 nm gold
NSPs and NSP-Panitumumab conjugates (antibody specific to EGFR that
is overexpressed in HN31 cells); B: Effects of EGFR-specific antibodies
C225 and Panitumumab as targeting vectors in HN31 cell model show 5
different combinations of the two antibodies; C: Effects of single and
dual targeting antibodies against PSMA and EGFR (C225) in C4-2B cell
model applied in combination with dual simultaneous optical excitation
(so called rainbow PNB method) show synergistic enhancement of PNB
lifetime in the rainbow mode.
doi:10.1371/journal.pone.0034537.g005
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signals in target (HN31) and non-target (NOM9) cells after active
targeting with NP-Panitumumab conjugates (Figure 4) and passive
targeting with ‘‘bare’’ identical NPs (Figure 5a) obtained under
identical NP concentrations, incubation time and laser parameters, we
concluded that the interaction of the targeting vector with specific
cellular receptor is very important. The fact that passive targeting of
both target and non-target cells returned no PNBs and the level of NP
scattering was close to that of background means that the
accumulation of bare non-conjugated NPs was very low and even
endocytosis could not form a significant cluster due to the presumably
low number of NPs accumulated at the cellular membrane. This
assumption is fully in line with our previous data [39,49] where we
studied in detail the difference in cellular uptake of conjugated and
bare gold NPs. These previous studies were performed only for one
type of cell (only target cells were incubated without the comparison
with non-target cells) and they directly showed a 10–100 fold
reduction in the uptake of bare NPs [64] and a 20–80 fold increase in
PNB generation threshold fluence compared to the same cells treated
with conjugated NPs [38,39]. Therefore, the combination of a
sufficient number of specific receptors (typical for target cells) with NP
vectors (active targeting) provides a maximal initial level of gold NPs
accumulated at the cellular membrane.
1.2. Activity of endocytosis. Endocytosis works as a universal
process that takes NPs from the cellular membrane and concentrates
them into clusters in the endo-lysosomal system. Due to the well-
known safety of the formation of clusters of gold NPs, this is a relatively
safe process providing that such NPs do not carry any toxic molecules
[12,38–46]. Our previous studies showed a significant reduction in NP
cluster size and a decrease in PNB signals in target cells in response to
the suppression of endocytosis in cells that accumulated a sufficient
amount of gold NPs at their membranes [49].
Therefore, the size of the NP cluster built by a cell depends upon
the activity of the clustering process (endocytosis) and the amount of
NPs available at the cellular membrane. This mechanism does not
prevent the formation of NP clusters in non-target cells, as we
observedinourexperiments (Figure4, row a),and wefound thatthis
is a general rule. However, we also observed that non-target cells
could not build as large NP clusters as target cells (Figure 4, row a)
and,therefore,the mechanism of formation ofthe largestNPclusters
(as PNB sources) is target cell-specific. By adjusting the laser fluence
to the level matching the largest NP clusters (as demonstrated in
Figure 2a and b) we provided the generation of PNBs only around
the largest NP clusters associated with target cells. At the same time
this fluence was not sufficient to generate PNB in non-target cells
regardless the formation of small NP clusters. This principle is
directly demonstrated by Figure 2b and it explains the much higher
cellular specificity of PNB compared to the receptor-mediated active
targeting of NPs. In many cases we observed only one PNB per
target cell. This assumes the formation of at least one large NP
cluster that was earlier found to be sufficient to support diagnostic
and therapeutic functions of PNB (see the next section).
Based upon our previous findings we may estimate the size of NP
clusters in the range of 5–100 NPs or 100–600 nm (for NPs with the
diameter 50–60 nm) [39,64]. Therefore, we conclude that the PNB
is a universal mechanism for discriminating between target and non-
target cells that demonstrates much higher specificity compared to
that of NPtargeting and can be considered as a universal solution for
overcoming unwanted effects of non-specific cellular uptake of NPs.
2. Feasibility of PNBs for medicine
The high cellular specificity of any nano-agent makes sense only
providing that such an agent can support the required biomedical
functions. While the study of the biomedical effects of PNBs is
outside the scope of this work, we may point out several cell-level
effects observed earlier. We recently demonstrated in vitro and in vivo
how optical, acoustical and mechanical localized tunable impacts of
PNBs support five biomedical functions that are determined by the
maximal size of the PNB which, in turn, is precisely controlled
through the fluence of the laser pulse. These functions are
diagnostics [40,56,57,82], delivery of intracellular and extracellular
molecular cargo [59–62], mechanical destruction of target cells
[38,40,49,57,61,63,64], microsurgery [64,65] and theranostics (the
method that unites diagnosis, treatment and guidance of the
treatment in one connected procedure) [40,57,63,80]. All these
functionswereactivatedondemand andrealized withcellselectivity
withasinglelaserpulseofspecificfluence,wavelengthandduration.
Such a short activation mechanism allows the reduction of the
duration of the biomedical procedures to nano- and micro-seconds.
In addition,we observed that the generation of evena single PNB in
the target cell was sufficient to achieve the desired biomedical effect.
This required a single NP cluster with a maximum of 100 particles.
Therefore, the PNB mechanism provides a significant reduction of
the NP load by several orders of magnitude, compared to other
diagnostic and therapeutic methods based on gold NPs [1–7,11,20–
29,83–90]. The clustering mechanism of NPs considered above is
not limited to endocytosis and may also employ the capability of
NPs to self-assemble in various structures under specific conditions
including NP clustering at the cellular membrane due to the co-
localization of the receptors, fusion of endosomes and other
chemical and biological mechanisms [91]. The combinatorial use
of NP targeting vectors (defined in many labs) with the rainbow
mechanism of PNBs [63,80] provides the potential for a further
improvement in specificity of the PNB effect in the complex
biological environment of the human body. In addition, the PNB
mechanism can be generalized to other types of non-gold NPs by
co-localizing gold NPs (as PNB sources) with other NPs (such as
drug carriers, for example). Recently we demonstrated how the
intracellular delivery of the commercially available anti-cancer
drug, doxorubicin liposomes (Doxil), can be improved through the
mixed administration and clustering of gold NPs with Doxil and the
intracellular release of the drug with co-localized PNBs [62].
In summary, we demonstrated that the specificity of the optical
activation of nanoparticles in target cells can be improved by more
than one order of magnitude through the threshold mechanism of
plasmonic nanobubbles (PNBs). Due to its threshold nature the PNB
method effectively discriminates between target and non-target cells
under the identical treatment of both with nanoparticles and optical
radiation. By combining the threshold nature of PNBs and the en-
hanced accumulation and clustering of nanoparticles in target cells, we
showed that PNBs, unlike nanoparticles, can be minimized or totally
avoided in non-target cells despite the uncontrollable non-specific up-
take of nanoparticles by such cells. The PNB method will be com-
patible with many existing nanomedicine technologies in development,
and will significantly improve their precision and selectivity.
Supporting Information
Text S1 The detailed descriptions of cell models and the
methods of plasmonic nanobubbles generation and detection.
(DOCX)
Figure S1 The expression level of EGFR in HN31 (cancer) and
NOM9 (normal) cells as measured with Western blot method.
(TIF)
Figure S2 The expression level of CD3 receptor in human T-
cells in the two cell samples of the peripheral blood mononuclear
cells, target (CD3+) and non-target (CD32) cells (the samples were
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from Beckman Coulter, Brea, CA).
(TIF)
Figure S3 Experimental scheme for plasmonic nanobubble
(PNB) generation and detection: single gold NP clusters or
individual cells in the sample chamber were mounted on the
stage of inverted optical microscope; PNB generation was
provided by the pulsed pump laser; a pulsed probe laser provided
time-resolved optical scattering imaging of PNBs and a continuous
probe laser provided the monitoring of the PNB size through its
time-response.
(TIF)
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